PERC: Biweekly Report (28 October – 10 November 2020)

  • Version
  • Download 812
  • File Size 333.99 KB
  • File Count 1
  • Create Date 16 November 2020
  • Last Updated 20 December 2020

PERC: Biweekly Report (28 October - 10 November 2020)

The Partnership for Evidence-Based Response to COVID-19 (PERC) released a brief on 13 November that delves deeper into findings from its 24,000-person survey conducted in 18 African Union (AU) Member States on disruptions to essential health services since the start of the pandemic. As governments across Africa start to reinstitute more restrictive public health and social measures (PHSMs) to respond to the continent’s second wave, ensuring continued access to health care services will be critical in preventing morbidity and mortality not only from the virus itself, but from other infectious diseases. Although some vaccination campaigns have resumed, the World Health Organization (WHO) estimates that millions of children have been left unvaccinated and are at increased risk for tuberculosis, measles and malaria, among other diseases.

Disease Situation (28 October – 10 November)
• In Africa, new cases and deaths increased by 20% and 26%, respectively, between 28 October – 10 November compared to the previous two-week reporting period (14-27 October). Morocco, South Africa, Tunisia, Kenya and Libya accounted for more than three-fourths of new cases and deaths. The test per case ratio remains below the recommended range in 15 AU Member States (see table below). Three-fourths of AU Member States are reporting community transmission.

• Morocco (61,432 new cases) continues to be at the epicenter of Africa’s second wave, reporting nearly three-fold the number of cases South Africa (22,403 new cases) reported between 28 October – 10 November. Kenya reported its highest number of new daily COVID-19 cases, and a 50% increase in new deaths during this reporting period.

• Algeria, Benin, Ghana, Somalia and Sudan saw new cases increase by more than 100% in this reporting period. Sudan reported a 665% increase in cases (574 new cases) and 279 new deaths in this reporting period, compared to only 77 new cases and 1 new death between 14-27 October. The test per case ratio remained below the recommended range in Algeria, Sudan and Somalia, at less than 7 tests per case, indicating many cases are likely going undetected.

• Uganda, which saw an 84% increase in new cases, reported 39 tests per case, which is within the recommended range.1 However, despite the recent rise in cases, the government moved to loosen restrictions on public gatherings in an effort to restore the economy.

• In Kenya, the media continued to report on rising cases among health care workers, with the increase attributed to a lack of personal protective equipment (PPE) available at hospitals. A large referral hospital in rural Kenya closed after 8 health care workers tested positive on 5 November.

 

Attached Files

FileAction
PERC BiWeekly Report - 16 November 2020 Download

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload